Intelligence / Healthtech / New Clinical Trials / BeOne Medicines
Clinicaltrial registered26 Oct 2026
BeOne Medicines
26 Oct 2026: Trial registered · An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 26 Oct 2026
- Title
- An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors
- Conditions
- Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Reference
- NCT07893535
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at BeOne Medicines
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for BeOne Medicines in our registers.
12 NovBeOne Medicinestrial registered · HealthtechClinical3 NovBeOne Medicinestrial registered · HealthtechClinical29 OctBeOne Medicinestrial registered · HealthtechClinical27 OctBeOne Medicinestrial registered · HealthtechClinical21 OctBeOne Medicinestrial registered · HealthtechClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.